Advisor Group, Inc. - CLEVELAND BIOLABS INC ownership

CLEVELAND BIOLABS INC's ticker is CBLI and the CUSIP is 185860202. A total of 16 filers reported holding CLEVELAND BIOLABS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Advisor Group, Inc. ownership history of CLEVELAND BIOLABS INC
ValueSharesWeighting
Q4 2019$0250.0%0.00%
Q3 2019$0250.0%0.00%
Q2 2019$0250.0%0.00%
Q1 2019$0250.0%0.00%
Q4 2018$0250.0%0.00%
Q3 2018$0250.0%0.00%
Q2 2018$0250.0%0.00%
Q1 2018$0250.0%0.00%
Q4 2017$025
-32.4%
0.00%
Q3 2017$0370.0%0.00%
Q2 2017$0370.0%0.00%
Q1 2017$0370.0%0.00%
Q4 2016$0370.0%0.00%
Q3 2016$0370.0%0.00%
Q2 2016$0370.00%
Other shareholders
CLEVELAND BIOLABS INC shareholders Q1 2018
NameSharesValueWeighting ↓
VANGUARD GROUP INC 106,674$176,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 265$00.00%
BANK OF AMERICA CORP /DE/ 150$00.00%
WELLS FARGO & COMPANY/MN 46$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Advisor Group, Inc. 25$00.00%
GEODE CAPITAL MANAGEMENT, LLC 16,688$27,0000.00%
BlackRock Inc. 13,629$23,0000.00%
BANK OF MONTREAL /CAN/ 31$00.00%
GROUP ONE TRADING, L.P. 68$00.00%
View complete list of CLEVELAND BIOLABS INC shareholders